| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biochemistry |
Department of Internal Medicine I [H. B., I. H. E., K. S-O., S. W.] and Department of Physical Biochemistry of the Institute of Physiological Chemistry [W. V.], Eberhard-Karls-University, D-72076 Tübingen, Germany
Mistletoe lectin I (ML-I) is a major active component in plant extracts of Viscum album that is increasingly used in adjuvant cancer therapy. ML-I exerts potent immunomodulating and cytotoxic effects, although its mechanism of action is largely unknown. We show that treatment of leukemic T- and B-cell lines with ML-I induced apoptosis, which required the prior activation of proteases of the caspase family. The involvement of caspases is demonstrated because (a) a peptide caspase inhibitor almost completely prevented ML-I-induced cell death and (b) proteolytic activation of caspase-8, caspase-9, and caspase-3 was observed. Because caspase-8 has been implicated as a regulator of apoptosis mediated by death receptors, we further investigated a potential receptor involvement in ML-I-induced effects. Cell death triggered by ML-I was neither attenuated in cell clones resistant to CD95 nor in cells that were rendered refractory to other death receptors by overexpressing a dominant-negative FADD mutant. In contrast, ML-I triggered a receptor-independent mitochondria-controlled apoptotic pathway because it rapidly induced the release of cytochrome c into the cytosol. Because ML-I was also observed to enhance the cytotoxic effect of chemotherapeutic drugs, these data may provide a molecular basis for clinical trials using MLs in anticancer therapy.
This article has been cited by other articles:
|
|
 |
|
  S. R. ELLURU, J.-P. D. VAN HUYEN, S. DELIGNAT, F. PROST, D. HEUDES, M. D. KAZATCHKINE, A. FRIBOULET, and S. V. KAVERI Antiangiogenic Properties of Viscum Album Extracts Are Associated with Endothelial Cytotoxicity Anticancer Res, August 1, 2009; 29(8): 2945 - 2950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Distler, J. Souady, M. Hulsewig, I. Drmic-Hofman, J. Haier, A. Denz, R. Grutzmann, C. Pilarsky, N. Senninger, K. Dreisewerd, et al. Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer Mol. Cancer Ther., August 1, 2008; 7(8): 2464 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bagaria, K. Surendranath, U. A. Ramagopal, S. Ramakumar, and A. A. Karande Structure-Function Analysis and Insights into the Reduced Toxicity of Abrus precatorius Agglutinin I in Relation to Abrin J. Biol. Chem., November 10, 2006; 281(45): 34465 - 34474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nencioni, F. Hua, C. P. Dillon, R. Yokoo, C. Scheiermann, M. H. Cardone, E. Barbieri, I. Rocco, A. Garuti, S. Wesselborg, et al. Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis Blood, April 15, 2005; 105(8): 3255 - 3262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hajto, K. Hostanska, T. Berki, L. Palinkas, F. Boldizsar, and P. Nemeth Oncopharmacological Perspectives of a Plant Lectin (Viscum album Agglutinin-I): Overview of Recent Results from In vitro Experiments and In vivo Animal Models, and Their Possible Relevance for Clinical Applications Evid. Based Complement. Altern. Med., March 1, 2005; 2(1): 59 - 67. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Schoffski, S. Riggert, P. Fumoleau, M. Campone, O. Bolte, S. Marreaud, D. Lacombe, B. Baron, M. Herold, H. Zwierzina, et al. Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group Ann. Onc., December 1, 2004; 15(12): 1816 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-H. Kim, W. B. Park, B. Gao, and M. H. Jung Critical Role of Reactive Oxygen Species and Mitochondrial Membrane Potential in Korean Mistletoe Lectin-Induced Apoptosis in Human Hepatocarcinoma Cells Mol. Pharmacol., December 1, 2004; 66(6): 1383 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Neumeister, M. Faigle, K. Lauber, H. Northoff, and S. Wesselborg Legionella pneumophila induces apoptosis via the mitochondrial death pathway Microbiology, November 1, 2002; 148(11): 3639 - 3650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Varghese, H. Sade, P. Vandenabeele, and A. Sarin Head Involution Defective (Hid)-triggered Apoptosis Requires Caspase-8 but Not FADD (Fas-associated Death Domain) and Is Regulated by Erk in Mammalian Cells J. Biol. Chem., September 13, 2002; 277(38): 35097 - 35104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lavastre, M. Pelletier, R. Saller, K. Hostanska, and D. Girard Mechanisms Involved in Spontaneous and Viscum album Agglutinin-I-Induced Human Neutrophil Apoptosis: Viscum album Agglutinin-I Accelerates the Loss of Antiapoptotic Mcl-1 Expression and the Degradation of Cytoskeletal Paxillin and Vimentin Proteins Via Caspases J. Immunol., February 1, 2002; 168(3): 1419 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chatterjee, I. Schmitz, A. Krueger, K. Yeung, S. Kirchhoff, P. H. Krammer, M. E. Peter, J. H. Wyche, and P. Pantazis Induction of Apoptosis in 9-Nitrocamptothecin-treated DU145 Human Prostate Carcinoma Cells Correlates with de Novo Synthesis of CD95 and CD95 Ligand and Down-Regulation of c-FLIPshort Cancer Res., October 1, 2001; 61(19): 7148 - 7154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-M. Boneberg and T. Hartung Mistletoe Lectin-1 Increases Tumor Necrosis Factor-alpha Release in Lipopolysaccharide-Stimulated Whole Blood via Inhibition of Interleukin-10 Production J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 996 - 1000. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Kurita-Ochiai, K. Ochiai, and K. Fukushima Butyric Acid-Induced T-Cell Apoptosis Is Mediated by Caspase-8 and -9 Activation in a Fas-Independent Manner Clin. Vaccine Immunol., March 1, 2001; 8(2): 325 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wieder, F. Essmann, A. Prokop, K. Schmelz, K. Schulze-Osthoff, R. Beyaert, B. Dorken, and P. T. Daniel Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3 Blood, March 1, 2001; 97(5): 1378 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Inman and M. J. Allday Apoptosis Induced by TGF-{beta}1 in Burkitt's Lymphoma Cells Is Caspase 8 Dependent But Is Death Receptor Independent J. Immunol., September 1, 2000; 165(5): 2500 - 2510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Walczak, A. Bouchon, H. Stahl, and P. H. Krammer Tumor Necrosis Factor-related Apoptosis-inducing Ligand Retains Its Apoptosis-inducing Capacity on Bcl-2- or Bcl-xL-overexpressing Chemotherapy-resistant Tumor Cells Cancer Res., June 1, 2000; 60(11): 3051 - 3057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Liu, M Kato, A. Akhand, A Hayakawa, H Suzuki, T Miyata, K Kurokawa, Y Hotta, N Ishikawa, and I Nakashima 4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death J. Cell Sci., January 2, 2000; 113(4): 635 - 641. [Abstract] [PDF]
|
|
|
|
|
|
K. Lauber, H. A. E. Appel, S. F. Schlosser, M. Gregor, K. Schulze-Osthoff, and S. Wesselborg The Adapter Protein Apoptotic Protease-activating Factor-1 (Apaf-1) Is Proteolytically Processed during Apoptosis J. Biol. Chem., August 3, 2001; 276(32): 29772 - 29781. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
